COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 357: Articles 3561-3570  | Next

Robust identification of perturbed cell types in single-cell RNA-seq data
Nicol, P. B., Paulson, D., Qian, G., Liu, X. S., Irizarry, R. A., Sahu, A. D.
10.1101/2023.05.06.539326 — Posted: 2023-05-08
A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice
Pandey, B., Wang, Z., Jimenez, A., Bhatia, E., Jain, R., Beach, A., Maniar, D., Hosten, J., O'Farrell, L., Vantucci, C., Hur, D., Noel, R. K., Ringquist, R. M., Smith, C., Ochoa, M. A., Roy, K.
10.1101/2023.05.05.539395 — Posted: 2023-05-08
SARS-COV-2 Spike Protein Fragment eases Amyloidogenesis of α-Synuclein
Hansmann, U. H. E., Maiti, B., Chesney, A. D.
10.1101/2023.05.06.539715 — Posted: 2023-05-08
Host inducible-HSP70A1A is an irresistible drug target to combat SARS-CoV-2 infection and pathogenesis
Joshi, P., Garg, S., Mani, S., Jakhar, K., Marothia, M., Shoaib, R., Biswas, S., Singhal, J., Behl, A., Kahlon, A. K., Shevtsov, M., Garg, P., Singh, S., Ranganathan, A.
10.1101/2023.05.05.539661 — Posted: 2023-05-08
The Coviral Portal: Multi-Cohort Viral Loads and Antigen-Test Virtual Trials for COVID-19
Morgan, A., Contreras, E., Yasuda, M., Dutta, S., Hamel, D. J., Shankar, T., Balallo, D., Riedel, S., Kirby, J. E., Kanki, P. J., Arnaout, R.
10.1101/2023.05.05.23289582 — Posted: 2023-05-07
Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19
Milross, L., Hunter, B., McDonald, D., Merces, G., Thompson, A., Hilkens, C. M. U., Wills, J., Rees, P., Jiwa, K., Cooper, N., Majo, J., Ashwin, H., Duncan, C. J. A., Kaye, P. M., Bayraktar, O. A., Filby, A., Fisher, A. J.
10.1101/2023.05.05.23289594 — Posted: 2023-05-07
Risk and loss aversion and attitude to COVID and vaccines in anxious individuals
Ferrari, F., Alexander, J., Series, P.
10.1101/2023.05.05.539520 — Posted: 2023-05-07
THE IMPACT OF THE COVID-19 PANDEMIC ON NON-COVID-19 COMMUNITY-ACQUIRED PNEUMONIA, A RETROSPECTIVE COHORT STUDY
Lee, T., Walley, K. R., Boyd, J. H., Cawcutt, K. A., Kalil, A. C., Russell, J. A.
10.1101/2023.05.04.23289541 — Posted: 2023-05-05
Descriptive Analysis of SARS-CoV-2 Genomics Data from Ambulatory Patients
Ambrose, N., Amin, A., Anderson, B., Bertagnolli, M., Campion, F., Chow, D., Drews, A., Farris, H., Gaspar, F. W., Jones, S., Korves, T., Lopansri, B., Musser, J., Neumann, E., O'Horo, J., Piantadosi, S., Pritt, B., Razonable, R. R., Roberts, S., Sandmeyer, S., Stein, D., Vahidy, F., Webb, B., Yttri, J.
10.1101/2023.05.03.23289106 — Posted: 2023-05-05
SARS-CoV-2 specific cellular and humoral immunity after bivalent BA.4/5 COVID-19 vaccination in previously infected and non-infected individuals
Urschel, R., Bronder, S., Klemis, V., Marx, S., Hielscher, F., Abu-Omar, A., Guckelmus, C., Schneitler, S., Baum, C., Becker, S. L., Gaertner, B. C., Sester, U., Widera, M., Schmidt, T., Sester, M.
10.1101/2023.05.03.23289472 — Posted: 2023-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).